Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Chlorpromazine versus Metoclopramide for Neurogenic Nausea and Vomiting in Incurable Patients with Gastrointestinal Tumors: A Prospective Observational Cohort Study

Saved in:
Bibliographic Details
Published in:Cancer Management and Research
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1870297336261902336
collection WordPress RSS
FRELIP Feed Integration
container_title Cancer Management and Research
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:101428
institution FRELIP
journal_source_facet Cancer Management and Research
last_indexed 2026-07-10T03:35:33.339Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Chlorpromazine versus Metoclopramide for Neurogenic Nausea and Vomiting in Incurable Patients with Gastrointestinal Tumors: A Prospective Observational Cohort Study
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Chlorpromazine versus Metoclopramide for Neurogenic Nausea and Vomiting in Incurable Patients with Gastrointestinal Tumors: A Prospective Observational Cohort Study
title_alt Clorpromazina versus Metoclopramida para náuseas y vómitos neurogénicos en pacientes incurables con tumores gastrointestinales: Un estudio de cohorte observacional prospectivo
Chlorpromazine versus métoclopramide pour les nausées et vomissements neurogènes chez les patients incurables atteints de tumeurs gastro-intestinales : une étude de cohorte observationnelle prospective
Clorpromazina versus Metoclopramida para náuseas e vômitos neurogênicos em pacientes incuráveis com tumores gastrointestinais: Um estudo de coorte observacional prospectivo
title_auth Chlorpromazine versus Metoclopramide for Neurogenic Nausea and Vomiting in Incurable Patients with Gastrointestinal Tumors: A Prospective Observational Cohort Study
title_es_txt Clorpromazina versus Metoclopramida para náuseas y vómitos neurogénicos en pacientes incurables con tumores gastrointestinales: Un estudio de cohorte observacional prospectivo
title_fr_txt Chlorpromazine versus métoclopramide pour les nausées et vomissements neurogènes chez les patients incurables atteints de tumeurs gastro-intestinales : une étude de cohorte observationnelle prospective
title_full Chlorpromazine versus Metoclopramide for Neurogenic Nausea and Vomiting in Incurable Patients with Gastrointestinal Tumors: A Prospective Observational Cohort Study
title_fullStr Chlorpromazine versus Metoclopramide for Neurogenic Nausea and Vomiting in Incurable Patients with Gastrointestinal Tumors: A Prospective Observational Cohort Study
title_full_unstemmed Chlorpromazine versus Metoclopramide for Neurogenic Nausea and Vomiting in Incurable Patients with Gastrointestinal Tumors: A Prospective Observational Cohort Study
title_pt_txt Clorpromazina versus Metoclopramida para náuseas e vômitos neurogênicos em pacientes incuráveis com tumores gastrointestinais: Um estudo de coorte observacional prospectivo
title_short Chlorpromazine versus Metoclopramide for Neurogenic Nausea and Vomiting in Incurable Patients with Gastrointestinal Tumors: A Prospective Observational Cohort Study
title_sort chlorpromazine versus metoclopramide for neurogenic nausea and vomiting in incurable patients with gastrointestinal tumors: a prospective observational cohort study
topic Oncology
General
Oncology
url https://www.dovepress.com/chlorpromazine-versus-metoclopramide-for-neurogenic-nausea-and-vomitin-peer-reviewed-fulltext-article-CMAR